{
    "clinical_study": {
        "@rank": "10077", 
        "arm_group": [
            {
                "arm_group_label": "isotonic magnesium sulphate", 
                "arm_group_type": "Experimental", 
                "description": "2.5 ml of isotonic magnesium sulphate (150 mg, 245 mmol/L) on three occasional at 20 minutes interval"
            }, 
            {
                "arm_group_label": "50% magnesium sulphate", 
                "arm_group_type": "Active Comparator", 
                "description": "magnesium sulphate 50mg/kg/dose intravenous drip in 20 minutes for one dose"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether nebulized magnesium sulphate is effective\n      in the treatment of acute severe asthma when comparison with intravenous magnesium sulphate"
        }, 
        "brief_title": "Compare Efficacy Nebulized and Intravenous Magnesium Sulphate in Thai Children", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Severe Asthma", 
        "condition_browse": {
            "mesh_term": [
                "Asthma", 
                "Status Asthmaticus"
            ]
        }, 
        "detailed_description": {
            "textblock": "Intervention: At randomization eligible patients were allocated to receive 2.5ml of isotonic\n      magnesium sulphate (150 mg,245 mmol/L) on three occasional at 20 minutes interval or\n      standard treatment 50 mg/kg intravenous magnesium sulphate. The asthma severity score was\n      record at 0,20,40,60,120,180,240 minutes post randomization. Adverse event were assessed at\n      each assessment point. Patients were followed up until discharge from hospital to collect\n      secondary outcome data."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children age 2-15 years presenting with severe asthma or persistent wheeze without\n             responding to conventional therapy\n\n        Exclusion Criteria:\n\n          -  chronic lung disease\n\n          -  history of adverse reaction form magnesium sulphate\n\n          -  life threatening condition"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "15 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02112305", 
            "org_study_id": "EC 104/2557"
        }, 
        "intervention": [
            {
                "arm_group_label": "isotonic magnesium sulphate", 
                "intervention_name": "isotonic magnesium sulphate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "50% magnesium sulphate", 
                "intervention_name": "50% magnesium sulphate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Magnesium Sulfate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Magnesium sulphate nebulized", 
        "lastchanged_date": "April 9, 2014", 
        "location": {
            "contact": {
                "email": "tassalapa@gmail.com", 
                "last_name": "Tassalapa Deangsuwan, Pediatrician"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10400"
                }, 
                "name": "Queen Sirikit National Institute of Child Health"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison Efficacy of Nebulized Magnesium Sulphate to Intravenous Magnesium Sulphate in Children With Severe Acute Asthma", 
        "overall_official": {
            "affiliation": "Queen Sirikit National Institute of Child Health", 
            "last_name": "Tassalapa Daengsuwan, Pediatrician", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ministry of Public Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Asthma severity score", 
            "safety_issue": "Yes", 
            "time_frame": "60 minute"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02112305"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Queen Sirikit National Institute of Child Health", 
            "investigator_full_name": "Tassalapa Daengsuwan", 
            "investigator_title": "medical doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "24144222", 
            "citation": "Powell CV, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, Hood K, Williamson PR; MAGNETIC study group. MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children. Health Technol Assess. 2013 Oct;17(45):v-vi, 1-216. doi: 10.3310/hta17450."
        }, 
        "secondary_outcome": {
            "measure": "Length of stay in the hospital", 
            "safety_issue": "No", 
            "time_frame": "within 2 weeks"
        }, 
        "source": "Queen Sirikit National Institute of Child Health", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Queen Sirikit National Institute of Child Health", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}